Point of care services

Doctor and patient
#Cell and gene therapy #Investment #Point of care services #United States

CGT company secures investment for point of care services

Orgenesis has agreed up to $50 million investment from Metalmark Capital in its US-based point of care services subsidiary, Morgenesis.  The investment will consist of an upfront investment of $30 million and two future investments of $10 million each, subject to the achievement of certain milestones. … Read More

#Business & Investment #News